Article Menu

Academic Editors

Neville Hacker

Xavier Sastre-Garau
Recommended Articles
Related Info Link
- Google Scholar
More by Authors Links

Article Views

Citations -

Altmetric Share Help Cite Discuss in SciProfiles

Need Help?

Support

Find support for a specific problem in the support section of our website.

Get Support

Feedback

Please let us know what you think of our products and services.

Give Feedback

Information

Visit our dedicated information section to learn more about MDPI.

Get Information

Open AccessArticle

Article Versions Notes

Cancers 2026, 18(11), 1695; https://doi.org/10.3390/cancers18111695

Action	Date	Notes	Link
article pdf uploaded.	22 May 2026 16:51 CEST	Version of Record	https://www.mdpi.com/2072-6694/18/11/1695/pdf

Cite

Export citation file: BibTeX | EndNote | RIS

MDPI and ACS Style

Molina-Hinojosa, C.L.; Carreras-Collado, R.; Saumoy-Linares, M.; Peñafiel, J.; Heydari, F.; Martí, J.C.; Fernández-Montolí, M.E. Long-Term Risk of Residual or Recurrent CIN 2–3 After LLETZ in Immunosuppressed vs. Immunocompetent Women: A 20-Year Cohort Study. Cancers 2026, 18, 1695. https://doi.org/10.3390/cancers18111695

AMA Style

Molina-Hinojosa CL, Carreras-Collado R, Saumoy-Linares M, Peñafiel J, Heydari F, Martí JC, Fernández-Montolí ME. Long-Term Risk of Residual or Recurrent CIN 2–3 After LLETZ in Immunosuppressed vs. Immunocompetent Women: A 20-Year Cohort Study. Cancers. 2026; 18(11):1695. https://doi.org/10.3390/cancers18111695

Chicago/Turabian Style

Molina-Hinojosa, Christian Leonardo, Ramón Carreras-Collado, María Saumoy-Linares, Judith Peñafiel, Fatima Heydari, Joan Climent Martí, and María Eulalia Fernández-Montolí. 2026. "Long-Term Risk of Residual or Recurrent CIN 2–3 After LLETZ in Immunosuppressed vs. Immunocompetent Women: A 20-Year Cohort Study" Cancers 18, no. 11: 1695. https://doi.org/10.3390/cancers18111695

APA Style

Molina-Hinojosa, C. L., Carreras-Collado, R., Saumoy-Linares, M., Peñafiel, J., Heydari, F., Martí, J. C., & Fernández-Montolí, M. E. (2026). Long-Term Risk of Residual or Recurrent CIN 2–3 After LLETZ in Immunosuppressed vs. Immunocompetent Women: A 20-Year Cohort Study. Cancers, 18(11), 1695. https://doi.org/10.3390/cancers18111695

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI